膀胱癌PD-1/PD-L1表达与18F-FDG摄取的关系
该回顾性研究纳入63例术前行18F-FDG PET/CT的膀胱癌患者,分析SUVmax与PD-1/PD-L1表达的关系。结果显示PD-1阳性者及PD-L1阳性者的SUVmax均显著高于相应阴性者,多因素分析中SUVmax与两者表达均显著相关;以SUVmax 22.7为界值可在一定准确度下预测PD-1/PD-L1状态。
要点
- 膀胱癌18F-FDG摄取越高,PD-1/PD-L1表达越高,两者存在关联。
- 以SUVmax 22.7为界值预测PD-1与PD-L1状态的准确率分别为71.4%和77.8%。
- 18F-FDG PET/CT有望辅助预测膀胱癌PD-1/PD-L1状态以指导治疗决策。
核心结论
- 膀胱癌较高的18F-FDG摄取与PD-1/PD-L1表达升高相关。
- 18F-FDG PET/CT可能有助于预测膀胱癌PD-1/PD-L1状态并确定最佳治疗策略。
研究设计与样本
- 回顾性分析63例在手术切除前接受18F-FDG PET/CT检查的膀胱癌患者,测定最大标准化摄取值(SUVmax)。
主要发现
- PD-1阳性患者SUVmax显著高于PD-1阴性患者(33.0 ± 13.9 对 19.6 ± 14.2,P = 0.032)。
- PD-L1阳性患者SUVmax显著高于PD-L1阴性患者(29.1 ± 15.6 对 15.8 ± 11.4,P < 0.0001)。
- 多因素分析中SUVmax与PD-1表达(P = 0.021)及PD-L1表达(P = 0.003)均显著相关。
关键数值与推荐
- 以SUVmax界值22.7预测PD-1状态的准确率为71.4%,预测PD-L1状态的准确率为77.8%。
临床怎么用
- 对拟行免疫检查点抑制剂治疗的膀胱癌患者,可参考18F-FDG PET/CT的SUVmax辅助判断PD-1/PD-L1状态。
- SUVmax较高提示PD-1/PD-L1表达可能升高,有助于个体化制定治疗策略。
局限性
- 本文为回顾性研究,样本量为63例,结论需进一步研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Immunotherapy aimed at inhibiting the PD-1/PD-L1 immune checkpoint has been approved and used successfully for the treatment of bladder cancer. The identification of markers predictive of response to immune checkpoint inhibitors is critical to advancing the success of this therapy. 18F-FDG PET/CT is a molecular imaging technique that can provide phenotypic information on malignant tumours. It is currently unknown whether there is a relationship between 18F-FDG uptake and expression of PD-1/PD-L1 in bladder cancer. In this study, we investigated whether PD-1/PD-L1 expression is associated with 18F-FDG uptake in bladder cancer, and whether 18F-FDG PET/CT imaging can be used to predict the PD-1/PD-L1 status of bladder cancer. METHODS: A retrospective analysis was performed in 63 patients with bladder cancer who had undergone 18F-FDG PET/CT before surgical resection. Maximum standardized uptake values (SUVmax) were determined. RESULTS: SUVmax was significantly higher in PD-1-positive patients than in PD-1-negative patients (33.0 ± 13.9 and 19.6 ± 14.2, respectively; P = 0.032), and in PD-L1-positive patients than in PD-L1-negative patients (29.1 ± 15.6 and 15.8 ± 11.4, respectively; P < 0.0001). In a multivariate analysis SUVmax was significantly associated with both PD-1 expression and PD-L1 expression (P = 0.021 and P = 0.003, respectively). Using a SUVmax cut-off value of 22.7, PD-1 status and PD-L1 status could be predicted with accuracies of 71.4% and 77.8%, respectively. CONCLUSION: Higher 18F-FDG uptake by bladder cancer is associated with elevated PD-1/PD-L1 expression. 18F-FDG PET/CT may be useful for predicting the PD-1/PD-L1 status of bladder cancer and for determining the optimal therapeutic strategy.
引用
- Chen R, Zhou X, Liu J, et al. Relationship between the expression of PD-1/PD-L1 and 18F-FDG uptake in bladder cancer. Eur J Nucl Med Mol Imaging. 2019. PMID: 30627815. doi:10.1007/s00259-018-4208-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。